Published in J Clin Endocrinol Metab on February 11, 2010
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Thyroid status and 6-year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area Study. J Am Geriatr Soc (2013) 2.10
2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J (2013) 1.87
Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab (2012) 1.75
The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab (2012) 1.33
Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab (2012) 1.08
A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol (2012) 1.01
Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging (2012) 1.00
Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease. J Lipids (2011) 0.97
Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab (2015) 0.96
Subclinical hypothyroidism: Controversies to consensus. Indian J Endocrinol Metab (2013) 0.93
Thyroid hormones and cardiovascular disease. Nat Rev Cardiol (2016) 0.93
Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern Med (2015) 0.92
Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort. PLoS One (2015) 0.91
The TSH upper reference limit: where are we at? Nat Rev Endocrinol (2011) 0.90
Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab (2013) 0.90
Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin Endocrinol Metab (2013) 0.86
Thyroid dysfunction in the elderly. Nat Rev Endocrinol (2013) 0.85
Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review). Exp Ther Med (2014) 0.85
Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality. PLoS One (2015) 0.82
Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment. BMC Endocr Disord (2015) 0.82
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab (2016) 0.81
Pleiotropic effects of thyroid hormones: learning from hypothyroidism. J Thyroid Res (2011) 0.80
Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome. Biotechnol Biotechnol Equip (2014) 0.80
Mortality and coronary heart disease in euthyroid patients. Am J Med (2012) 0.79
Serum Phospholipase A2-IIA, hs-CRP, and Lipids in Women With Subclinical Hypothyroidism. Int J Endocrinol Metab (2014) 0.79
Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site. P R Health Sci J (2013) 0.79
Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat Rev Endocrinol (2016) 0.78
Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiency. Front Endocrinol (Lausanne) (2014) 0.78
Serum Thyroid Stimulating Hormone Levels Are Associated with the Presence of Coronary Atherosclerosis in Healthy Postmenopausal Women. J Menopausal Med (2016) 0.77
Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women. Thyroid (2014) 0.77
The evaluation of diastolic dysfunction with tissue Doppler echocardiography in women with subclinical hypothyroidism and the effect of L-thyroxine treatment on diastolic dysfunction: a pilot study. J Thyroid Res (2011) 0.77
LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation. Lipids Health Dis (2015) 0.76
Incidence of subclinical hypothyroidism in renal transplant patients. Mater Sociomed (2015) 0.76
The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients. Res Cardiovasc Med (2015) 0.76
The debate on treating subclinical hypothyroidism. Singapore Med J (2016) 0.75
Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab (2016) 0.75
Thyroid Hormone Profile in Patients With Acute Coronary Syndrome. Iran Red Crescent Med J (2015) 0.75
Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism - A Cohort Study. Sci Rep (2017) 0.75
Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women. J Endocr Soc (2017) 0.75
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest (2008) 2.69
The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab (2008) 2.35
Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med (2012) 1.79
Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab (2007) 1.49
Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol. Nucl Med Commun (2004) 1.44
The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab (2002) 1.44
How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol (Oxf) (2009) 1.43
Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev (2011) 1.36
Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab (2003) 1.14
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab (2007) 1.13
Unrecognised severe vitamin D deficiency. BMJ (2008) 1.12
Management of hypothyroidism in adults. BMJ (2008) 1.11
Role of the CD40 locus in Graves' disease. Thyroid (2004) 1.04
Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem (2003) 1.03
Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther (2011) 1.02
Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol (2012) 1.00
Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health (2009) 0.97
Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. J Clin Endocrinol Metab (2009) 0.97
Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1). Hum Mutat (2010) 0.96
Left ventricular apical ballooning (takotsubo cardiomyopathy) in thyrotoxicosis. Thyroid (2007) 0.94
Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol (2006) 0.94
Perrault syndrome: further evidence for genetic heterogeneity. J Neurol (2011) 0.91
The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy. Clin Endocrinol (Oxf) (2013) 0.87
Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment. J Clin Endocrinol Metab (2013) 0.87
Subclinical thyroid disorders: significance and clinical impact. J Clin Pathol (2010) 0.85
Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people. J Clin Endocrinol Metab (2012) 0.85
Anti-neutrophil cytoplasmic antibody (ANCA) associated small-vessel vasculitis in a patient with diabetic nephropathy and autoimmune polyendocrinopathy syndrome (APS) Type 2: a case report. Clin Nephrol (2013) 0.85
Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol (Oxf) (2007) 0.84
Extracellular calcium-sensing receptor dysfunction is associated with two new phenotypes. Clin Endocrinol (Oxf) (2003) 0.84
Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study. Eur J Hum Genet (2010) 0.83
Thyroid peroxidase forms thionamide-sensitive homodimers: relevance for immunomodulation of thyroid autoimmunity. J Mol Med (Berl) (2009) 0.81
No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease. Clin Endocrinol (Oxf) (2005) 0.79
Prevention and treatment of vitamin D deficiency. Calcif Tissue Int (2012) 0.78
Autoimmune Addison's disease. Presse Med (2012) 0.78
The role of a nonsynonymous CD226 (DNAX-accessory molecule-1) variant (Gly 307Ser) in isolated Addison's disease and autoimmune polyendocrinopathy type 2 pathogenesis. Clin Endocrinol (Oxf) (2011) 0.77
Toward precise forecasting of autoimmune endocrinopathy. J Clin Endocrinol Metab (2004) 0.77
What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease. Eur J Endocrinol (2006) 0.77
Discordance for X-linked hypophosphataemic rickets in identical twin girls. Horm Res (2009) 0.77
The role of functionally defective rare germline variants of sialic acid acetylesterase in autoimmune Addison's disease. Eur J Endocrinol (2012) 0.76
Disordered calcium crystal handling in antisense CLC-5-treated collecting duct cells. Biochem Biophys Res Commun (2003) 0.75
Primary hyperparathyroidism: just how 'primary' is it really? Ther Adv Endocrinol Metab (2010) 0.75
Correction: Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus. PLoS One (2015) 0.75
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary (2002) 0.75
Saving lives of in-patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle-upon-Tyne Hospitals e-Prescribing platform. Clin Endocrinol (Oxf) (2014) 0.75
Sun and melanoma: Time to go to get your hat. BMJ (2008) 0.75
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). BMC Psychiatry (2013) 0.75
Thyroid function tests and hypothyroidism. Restoring serum TSH to reference range should be goal of replacement. BMJ (2003) 0.75
Do antithyroid drugs influence outcome after radioiodine therapy for hyperthyroidism? Nat Clin Pract Endocrinol Metab (2007) 0.75
Genetic progress towards the molecular basis of common autoimmunity. Discov Med (2006) 0.75
How should I approach standard endocrine evaluation in patients with coeliac disease? Clin Endocrinol (Oxf) (2013) 0.75
Subclinical hypothyroidism and cardiovascular disease-reply. Arch Intern Med (2012) 0.75
Current and emerging therapies for Addison's disease. Curr Opin Endocrinol Diabetes Obes (2014) 0.75